Vitaliy Zhivotenko
Interventional Pain Medicine · Paradise Valley, AZNPI 1336431907
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $926 and has fallen 97.4% since, to $24 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in AZ, where the typical reported total is $8,993.
Across 126 payments — averaging $23.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$475
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$446
- AbbVie$294
- MML US, Inc.$237
- Relievant Medsystems, Inc.$181
- Lilly USA, LLC$166
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,971100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 22 | $475 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $446 |
| AbbVie | 12 | $294 |
| MML US, Inc. | 3 | $237 |
| Relievant Medsystems, Inc. | 1 | $181 |
| Lilly USA, LLC | 8 | $166 |
| Biohaven Pharmaceuticals, Inc. | 8 | $160 |
| Amgen(2 entities) | 5 | $99 |
| AstraZeneca(2 entities) | 5 | $93 |
| Biodelivery Sciences International, Inc. | 6 | $91 |
| Si-bone, Inc. | 2 | $84 |
| Collegium Pharmaceutical, Inc. | 5 | $79 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $69 |
| Pacira Therapeutics, Inc. | 3 | $50 |
| Spinefrontier, Inc. | 1 | $40 |
| Medtronic | 3 | $39 |
| Boston Scientific | 2 | $39 |
| Biogen | 2 | $35 |
| Nevro Corp. | 1 | $35 |
| Painteq LLC | 1 | $32 |
| Almatica Pharma LLC | 1 | $29 |
| Abbott | 2 | $28 |
| Vertex | 1 | $24 |
| Assertio Therapeutics, Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $21 |
| Indivior Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Virtus Pharmaceuticals LLC | 1 | $19 |
| Pfizer | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Baudax Bio Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,971 in reported general payments places this provider in the 30th percentile of 64 interventional pain medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 20 | $126 |
| Cyclobenzaprine Hcl | 14 | $59 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Paradise Valley
- Paul LynchScottsdale$283K
- Jack DiepLake Havasu City$233K
- Matthew RansonMesa$86K
- Steven SiwekPhoenix$57K
- Ajay YedduGilbert$52K
- Ramoun JonesPhoenix$51K
- Lisa StearnsPhoenix$48K
- Sachin NarainGilbert$31K
- Jennifer DaisPeoria$30K
- Brandon RothGlendale$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.